Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock
Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
Read More 6 minute read Healthcare Industry News Avita Medical (ASX: AVH) stock surges 25% after Europe clears Recell GO – but can momentum last? Avita Medical (ASX: AVH, NASDAQ: RCEL) stock soared 25% after CE Mark approval for RECELL GO in Europe. Explore how this milestone reshapes investor outlook. byPallavi MadhirajuSeptember 16, 2025